Healthcare
Raffles Medical net profit falls 9.6% to $29m in H1
Raffles Medical net profit falls 9.6% to $29m in H1
Its healthcare services division posted a 16% drop in revenue to $119.5m.
2 hours ago
Chinese Medicine Hospital launches integrated care programmes
First phase will prioritise post-stroke and lower-back-pain management.
4 hours ago
Mahkota Medical Centre to expand capacity to 430 beds by 2029
New block marks first major physical expansion since 1994.
5 hours ago
Can tax breaks make medicines more affordable?
The country remains heavily dependent on imported drugs.
6 hours ago
Imaging upgrades fuel Australia's CT scanner market growth to 2035
It accounted for 4% of the Asia-Pacific CT systems market in 2025.
3 days ago
South Korea lands $95.67m Novartis deal for radioligand therapy
It will focus on building an RLT manufacturing facility, amongst others.
3 days ago
Premium public care puts Thailand's private hospitals under pressure
The country launched 16 premium clinics across public hospitals.
3 days ago
NHL CAR-T therapy market reaches $3.2b
Market reached $3.2b in 2025, with the US accounting for 59% of total value.
4 days ago
Medtech braces for shift away from one-and-done products
Circularity may offset these pressures whilst creating new revenue streams.
4 days ago
Cleveland Clinic Abu Dhabi debuts wireless heart‑failure monitoring implant
It tracks arterial blood pressure.
5 days ago
India opens advanced mother‑and‑child, neuroscience centres at PGIMER
It also laid the foundation stone for a 150-bed Critical Care Block.
5 days ago
Acute pain market seen rising 12% annually on surgical demand
It was valued at $4.5b in 2025.
5 days ago
Asan Medical Centre fast-tracks trials in SK with new digital signing system
It provides identity verification through signer email authentication.
6 days ago
Burjeel, Roswell Park to set up thoracic surgery service in UAE
It aims to reduce the need for patients to travel overseas.
Bioinformatics market set to hit $34.41b on genomics boom
Asia Pacific is expected to register the highest growth rate.
Global GLP-1 market on track for $133.92b by 2034
Asia Pacific is projected to post the fastest regional growth.
Demand for custom implants to push market to $11.5b by 2036
Orthopaedic implants lead the market.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings